News: Research

Drug candidate developed by Everett Stone and his team is effective in mice with cancers of skin, bladder, blood and colon.

Alone, this target might not be strong enough to directly block infection, but it might be used to jump-start or boost an immune response.

New findings could lead to a vaccine for one more respiratory virus.

Jason McLellan and his team advance understanding of human metapneumovirus (hMPV) and human cytomegalovirus (HCMV), which can help them develop vaccines.

Inside the "biological foundry" at the Army Research Lab's ARL-South partnership on the campus of UT Austin

Most antibodies against SARS-CoV-2 circulating in the blood target areas of the viral spike protein outside the receptor binding domain, or RBD

A COVID-19 vaccine in human trials in Vietnam, Thailand and Brazil, holds promise for affordable vaccine manufacturing in countries currently dependent on imported vaccines.

The virus that causes COVID-19 is accumulating genetic mutations, one of which may have made it more contagious.

A redesigned version of the coronavirus spike protein called HexaPro might speed up vaccine production and yield a more effective immune response to SARS-CoV-2.

The hunt for an effective treatment for COVID-19 has led researchers to find an improbable ally for their work: a llama named Winter.